Photo by National Cancer Institute on Unsplash

The money raised will be used to further explore more possibilities for using computer science to empower innovations in the life sciences sector.

Aurora, a technology company specializing in the digitalization of the clinical research of life sciences, recently complete a Series A+ financing round worth tens of millions of USD. 

The round was led by the existing investor Hankang Equity Investment Management, with participation from B Capital. Huaxing Capital acted as its exclusive financial advisor. 

Founded in 2020 in Shanghai, China, Aurora focuses on the field of life science clinical research and development, and is committed to creating a world-leading new generation of clinical research SaaS platform, with cloud computing, big data, AI, enterprise-level B2B SaaS technology, thereby reducing costs and increasing efficiency. Aurora's team members are mainly from Google, Verily, Splunk, Medidata, Veeva, WuXi AppTec and other global leading companies in related fields. 

More By This Author:

Chip Designer Photonic Bags CNY Tens of Mns from Series C1 Financing Round
Wuxi Biologics Will Be Removed From U.S. Commerce Department's ‘Unverified List’
JHM Biopharma Raises CNY200 Million In Series A1 Funding Round